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Objectives
This paper examines changes in barriers to HIV testing amongst gay men. We compared data
collected in 2000 and 2010 to assess changes in HIV testing behaviours, in community-level
perceptions of barriers to HIV testing, and in the relative contributions of barrier measures.
Methods
Cross-sectional surveys were conducted within the commercial gay scene in Glasgow with good
response rates (78% and 62%) using a form of time and location sampling.
Results
Major changes in HIV testing behaviours were observed between 2000 and 2010 (30.6% increase
in testing within previous year). At the community level, the perceived benefits of testing [t
(1284) = –8.46; P < 0.001] and the norm for HIV testing [t (1236) = –11.62; P < 0.001] increased;
however, other perceived barriers did not change (fear of a positive result, clinic-related barriers
and attitudes to sex with HIV-positive men). Multinomial logistic regression showed that fear of
a positive test result remained a key barrier to HIV testing; however, a significant fear ¥ year of
survey interaction indicated that fear played a lesser role in differentiating those who had never
been tested from those who had been tested in 2010 than it had in 2000.
Conclusions
These findings suggest the partial normalization of HIV testing. While some barriers have
reduced, other key barriers remain important. Interventions should be designed and evaluated
that attend to both the biomedical and the psychosocial aspects of HIV testing (e.g. the meaning
of positive test results, the sexual exclusion of positive men, and HIV-related stigma).
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Introduction
While across Europe HIV prevention policies differ [1],
increasing both the number and frequency of HIV antibody
tests amongst men who have sex with men (MSM) remains
central to attempts to normalize HIV testing, reduce
undiagnosed HIV infection, prevent new HIV infections
and decrease HIV-related morbidity [2,3]. Treating HIV
infection like any other infectious disease is paramount [4].
HIV testing remains core to the clinical management of
HIV infection [5–7]; however, it now also figures as a core
part of HIV prevention, reflected for example in recent
constructs such as ‘treatment as prevention’ [8], other bio-
medical approaches to HIV prevention [9,10], and indeed
the range of older HIV testing-based risk-reduction strat-
egies such as serosorting [11].
The shift in HIV testing policy in the UK from opt-
in to opt-out testing [12] has been associated with
unprecedented increases in testing at the community level
[13,14], a drop in undiagnosed HIV infection [15], and
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potentially, given the likely transferability of findings from
the USA, a corresponding reduction in onwards transmis-
sion [16]. The simple change in routine service provision
has probably reduced many barriers to testing [13]. It has
removed, or at least diminished, the role of the HIV testing
decision-making process at the level of the patient/client.
In order to design and implement interventions to promote
the normalization of HIV testing [17], it is essential that we
identify and understand the remaining factors that appear
to either promote or deter people from testing [18] and
address barriers to regular, frequent testing [19]. Recent
publications have focused upon synthesizing the evidence
concerning barriers to HIV testing [20–22]. In a systematic
review of barriers to testing within Europe, Deblonde et al.
[21] considered barriers to testing at three distinct levels:
the patient/client level, the health care provider level, and
the institutional/policy level. At the level of the patient or
client, the key barriers appear to be low risk perception,
fear of HIV disease (and fear of the consequences of a
positive test result), fear of HIV disclosure (including dis-
crimination and rejection), and the accessibility of health
services. In addition to these barriers, De Wit and Adam
[20] identified the importance of the perceived benefits of
testing, which they suggest are rarely concerned with
antiretroviral therapy (ART). Equally, the importance of
patient-related barriers such as lack of perceived risk, a
lack of information regarding testing possibilities, stigma-
tization and fear of a positive test result have also been
highlighted [22].
Consequently, it is important to examine how, across this
period of change in levels of HIV testing, perceptions of
barriers to testing have changed at the community level –
thus identifying which factors remain perceived barriers.
Equally, it is important to examine which factors are actu-
ally associated with HIV testing behaviour and how these
have changed across time. The current paper examines five
measures of barriers to HIV testing, using data collected
from MSM in Scotland at two time-points: 2000 and 2010.
We examine three research questions: the extent of change
in HIV testing behaviours between 2000 and 2010; the
extent to which community-level perceptions of barriers to
testing have changed; and finally, the relative contribu-
tions of barrier measures (when controlling for differences
between 2000 and 2010) in understanding differences
between those tested recently (within the previous year),
those tested over 1 year previously (‘nonrecent testers’) and
those never tested.
Methods
We conducted two cross-sectional surveys (in 2000 and
2010) in commercial gay venues within Scotland. The same
time and location sampling strategy was used in both
surveys [13,23]. In 2000, 803 valid responses were col-
lected after approaching 1029 men (78%). In 2010, 822
valid responses were collected after approaching 1314
men (62%). To ensure comparability between samples, we
excluded men who did not give a Scottish postcode when
asked to indicate area of residence. We excluded respond-
ents who indicated that they were HIV-positive from the
current analysis as, once HIV has been diagnosed, further
HIV testing ceases. The maximum sample sizes for the
current analysis were 686 in 2000 and 696 in 2010. The
wording of the key HIV-related questions was the same in
both surveys. Ethical approval was granted by the Psychol-
ogy Ethics Committee at Glasgow Caledonian University.
Measures
Demographic variables included age and educational
qualifications (degree or postgraduate vs. school/
vocational). Sexual behaviour was assessed using the
number of unprotected anal intercourse (UAI) partners
reported in the year prior to data collection, categorized as
0, 1 or  2.
The dependent variable centred on HIV testing, specifi-
cally whether tested within the previous 6 months, 6–12
months previously, 1–5 years previously, over 5 years pre-
viously, or never tested. For additional analyses (see below)
these categories were recoded to form three groups of men:
recent testers (within the 12 months preceding data collec-
tion), nonrecent testers (tested at some point in their lives
but not within the 12 months preceding data collection),
and never testers (those who had never had an HIV test).
Five measures of barriers to testing were included in the
current analysis [1]: perceived benefits of HIV testing, which
consisted of three items: ‘If more people had an HIV test
there would be fewer new HIV infections’; ‘Having an HIV
test can help you plan your life’; ‘Having an HIV test puts
your mind at rest’ [2]; fear of a positive HIV test result,
which consisted of five items: ‘Fear of a positive result puts
me off testing’; ‘I do not want to test because of the
psychological consequences of a positive result’; ‘I would
rather get ill than find out I was HIV positive’; ‘I would
rather not knowmy HIV status than risk being told I am HIV
positive’; ‘It’s much better to live with an uncertain HIV
status than waking up every morning actually knowing
you’re positive’ [3]; clinic-related barriers, which consisted
of four items: ‘Clinics don’t open at the right times for gay
men to get tested’; ‘The way staff treat people when they get
tested puts them off having a test’; ‘Gay men avoid HIV
testing because they can’t bear waiting for the results’; ‘I
wouldn’t go for an HIV test if I had to wait more than a day
for the results’ [4]; attitudes towards sex with HIV-positive
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partners, which consisted of three items: ‘I wouldn’t have
anal sex with anyone I knew was HIV positive’; ‘I wouldn’t
have oral sex with anyone I knew was HIV positive’;
‘Nobody would want to have sex with me if they knew I was
HIV positive’; and [5] norm for HIV testing, which consisted
of one item: ‘Most of my gay friends have had an HIV test’.
All items were rated on five-point scales from 1 (‘strongly
disagree’) to 5 (‘strongly agree’). Scores were computed
from the mean of contributing items.
Analysis
The analysis was conducted using PASW STATISTICS 18.0 for
Macintosh (SPSS Inc., Chicago, IL, USA). Scores for barrier
measures were computed as means of contributing items,
allowing for one missing value. Missing values on barrier
items for both studies were imputed using the multiple
imputation option in PASW STATISTICS 18.0 for Macintosh,
provided that respondents had completed at least 50% of all
barrier items. Differences between the two samples were
investigated using c2 analysis or t-tests, as appropriate. For
the final analysis, multinomial logistic regression was used
to examine the variables that accounted for variation in HIV
testing behaviours. Variables were centred prior to inclusion
and the contributions of interaction terms between year of
survey and barriers to testing were examined after all main
variables had been entered. Alpha was set at 0.05 (two-
tailed). Where necessary, corrections were applied for
inequalities of variance.
Results
Descriptions of the two samples are presented in Table 1.
The samples differed significantly on age distribution, such
that in 2010 a higher proportion of the sample were aged
45 years or over, and a lower proportion were aged 25 to
34 years [c2 (3, n = 1358) = 12.47; P = 0.006]. Overall, those
sampled in 2010 were older than those sampled in 2000.
There were no differences in terms of educational quali-
fications. With regard to sexual behaviour, the 2010
respondents were more likely to indicate having had two or
more UAI partners, and less likely to have had no such
partners, than were the respondents sampled in 2000 [c2 (2,
n = 1322) = 14.62; P = 0.001].
As expected, the two samples differed significantly on
HIV testing behaviour. The key difference between the
samples lay in the proportions of those tested recently
( 12 months previously) compared with those who had
never been tested [c2 (2, n = 1322) = 157.83; P < 0.001].
Among those sampled in 2000, 26.6% (n = 170) had
been tested  12 months previously, and 49.8% (n = 318)
had never been tested. However, among those sampled
in 2010, 57.2% (n = 391) had been tested  12 months
previously, and 20.1% (n = 137) had never been
tested.
Changes in the perceived barriers to HIV testing are
shown in Table 2. Those sampled in 2010 gained
higher scores on the measures of testing benefits and
testing norm than did those sampled in 2000, indicative




(P-value)n % n %
Age 0.006
 24 years 178 26.7 198 28.7
25–34 years 264 39.6 219 31.7
35–44 years 169 25.3 187 27.1
 45 years 56 8.4 87 12.6
Educational qualifications 0.914
Secondary/vocational 390 60.5 418 60.8
Degree/postgraduate 255 39.5 270 39.2
UAI partners in previous year 0.001
0 400 62.3 359 52.8
1 184 28.7 225 33.1
 2 58 9.0 96 14.1
HIV testing* < 0.001
In previous 6 months 49 7.7 271 39.7
In previous 6–12 months 121 18.9 120 17.6
In previous 1–5 years 105 16.4 114 16.7
Over 5 years previously 46 7.2 41 6.0
Never tested 318 49.8 137 20.1
*Categories collapsed as follows prior to analysis: tested  12 months previously; > 12 months previously; never tested.
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of greater perceived benefit and a stronger testing
norm [t (1284) = –8.46; P < 0.001 and t (1236) = –11.62;
P < 0.001, respectively]. No differences between the
samples were observed in the scores on the measures of
fear of a positive test result, clinic-related barriers and
attitudes to sex with HIV-positive partners.
The final research question addressed the relative con-
tribution of factors to understanding differences between
those who were categorized as recent testers, nonrecent
testers and never testers. This was examined through multi-
nomial regression analysis. The dependent variable was
HIV testing behaviour (three categories), and the independ-
ent variables were year of survey, age (as a continuous
variable), level of educational qualification, number of UAI
partners reported in the previous year, and the five barriers
to testing. As noted above, there were significant differ-
ences between the years of survey in age and number of
UAI partners; further, HIV testing varied with age at both
time-points, and with number of UAI partners and with
education in 2000.
The number of respondents included in the multinomial
logistic regression analysis was 1133. The likelihood ratio
test was significant [c2 (20) = 395.74; P < 0.001], while the
Pearson goodness of fit test was not [c2 (2242) = 2256.79;
P = 0.409]: it therefore appeared that the model provided a
reasonable fit of the data. The overall percentage correctly
classified was 58.3%.
The results are shown in Table 3. When adjusted for year
of survey, age, education and number of UAI partners,
those who had never been tested were distinguished from
those who were recent testers by greater fear of a positive
HIV test result, by a weaker perceived norm for HIV testing,
by more negative attitudes to sex with HIV-positive part-
ners, and by weaker perceptions of the benefits of testing.
Those who had never been tested were distinguished from
nonrecent testers by greater fear of a positive test result, a
weaker perceived norm, and more negative attitudes to sex
with HIV-positive partners. Recent testers were distin-
guished from nonrecent testers only by fear of a positive
HIV test result.
Table 2 Changes in perceived barriers to testing at the community level
2000 2010
Difference
(P-value)a M SD a M SD
Perceived benefits of HIV testing 0.59 3.65 0.81 0.50 4.02 0.77 < 0.001
Fear of HIV-positive test result 0.82 2.19 0.85 0.83 2.21 1.03 0.698
Clinic-related barriers 0.58 2.48 0.70 0.63 2.55 0.86 0.106
Attitudes to sex with HIV-positive partners 0.68 3.45 0.92 0.68 3.54 1.04 0.092
HIV testing norm 2.96 0.89 3.61 1.13 < 0.001
M, mean; SD, standard deviation.















95% CI PAOR AOR AOR
Year of survey 4.86 3.46 6.84 < 0.001 2.26 1.57 3.27 < 0.001 2.15 1.52 3.03 < 0.001
Age 1.02 1.00 1.04 0.046 0.96 0.95 0.98 < 0.001 1.06 1.04 1.08 < 0.001
Education 1.25 0.90 1.73 0.175 1.53 1.08 2.16 0.017 0.82 0.60 1.13 0.227
UAI partners
0 1.71 1.03 2.85 0.039 0.96 0.52 1.77 0.895 1.78 1.04 3.06 0.036
1 1.47 0.86 2.51 0.163 0.77 0.41 1.46 0.425 1.90 1.08 3.35 0.025
Fear of HIV-positive test result 2.19 1.76 2.71 < 0.001 1.53 1.22 1.93 < 0.001 1.42 1.14 1.78 0.002
Clinic-related barriers 1.19 0.93 1.51 0.169 1.20 0.92 1.56 0.174 0.99 0.77 1.26 0.922
Attitudes to sex with HIV-positive
partners
1.24 1.04 1.48 0.019 1.35 1.11 1.63 0.002 0.92 0.78 1.09 0.330
Perceived benefits of HIV testing 0.75 0.60 0.93 0.010 0.92 0.73 1.16 0.459 0.82 0.65 1.02 0.073
HIV testing norm 0.57 0.48 0.67 < 0.001 0.64 0.53 0.77 < 0.001 0.89 0.76 1.05 0.160
Year ¥ fear 0.71 0.58 0.88 0.001 0.73 0.59 0.89 0.002 0.98 0.79 1.23 0.877
The reference group for year is 2000, that for education is graduate/postgraduate, and that for unprotected anal intercourse (UAI) partners is  2.
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It is also worth considering the contributions of the other
factors. First, it was noteworthy that nonrecent testers were
significantly older than both those who had never been
tested and recent testers. They were also more likely to
have a degree or postgraduate qualification than those who
had never been tested. With regard to UAI partners, recent
testers were more likely than either nonrecent testers or
never testers to have had  2 UAI partners in the previous
year.
In order to compare the roles of barriers between the two
time-points in more detail, each year ¥ barrier interaction
term was added separately to the equation. Only year ¥ fear
made a significant contribution (see Table 3). This contri-
bution centred on comparisons between those who had
never been tested and both recent testers and nonrecent
testers: the contribution of fear to the analysis was signifi-
cantly smaller in 2010 than it had been in 2000, such that
differences between never testers and other respondents on
fear of a positive test result were smaller.
In summary, the results highlight differences between
those who had never been tested and both recent and
nonrecent testers on fear of a positive test result, the norm
for testing and attitudes towards sex with HIV-positive
partners, irrespective of the year of data collection.
However, the role of fear of a positive test result changed
over time, such that it made a smaller contribution to the
explanation of variance in 2010 than it had done in 2000.
The results also highlight the role of fear in differentiating
between recent and nonrecent testers, irrespective of year
of data collection.
Discussion
Between 2000 and 2010, HIV testing in the 12 months
preceding data collection increased dramatically from 26.6
to 57.2%. Moreover, testing in the preceding 6 months
increased from 7.7 to 39.7%. Equally, the percentage of
participants who had never been tested dropped from 49.8
to 20.1%. These changes over time were independent of
both demographic factors and sexual behaviour. This rep-
resents a key change in HIV-related health behaviour akin
to the profound changes in condom use noted during the
1980s within this population, and, as we have reported
elsewhere, are coterminous with the policy change from
opt-in to opt-out HIV testing in genitourinary medicine
(GUM) clinics [13,24]. Here, we discuss why they suggest
the normalization of HIV testing.
Before addressing this and the implications of this paper
for policy development and further research, it is worth
rehearsing the limitations of this work. It relies on cross-
sectional research designs, examines samples of men
recruited through the commercial gay scene only, and relies
upon self-report data. It does not represent the evaluation
of any specific intervention designed to increase testing
nor does it focus upon the barriers to frequent testing.
Moreover, the reliability of some of our measures is vari-
able. However, the analysis reiterates major increases in
HIV testing behaviour, it describes changes in perceived
barriers to HIV testing at the community level, and it
highlights the reduced role of some barriers to HIV testing
and shows which ones remain important in explaining HIV
testing behaviours.
The 2010 data, when compared to other European data,
show that HIV testing rates now appear relatively high in
Scotland [22]. It is worth noting that within Scotland, in
addition to the change in testing policy within clinics from
opt-in to opt-out, there have recently been three mass
media campaigns (2008–2010) which have all promoted
both sexual health and HIV testing every 6 months
amongst those at risk of acquiring HIV infections and
sexually transmitted infections (STIs). Although this
finding is suggestive of the effectiveness of such cam-
paigns, it is worth noting that a recent systematic review of
the international evidence highlights that there is limited
evidence that multimedia social marketing campaigns can
effectively promote HIV testing among MSM in developed
countries [25]. It is also possible that increases in recent
HIV testing relate to increases in STI testing [26].
Significant differences were observed between the mean
scores of the two samples relating to both the perceived
benefits of HIV testing and the perceived norm of HIV
testing. Given the observed changes in testing behaviour, it
is perhaps unsurprising that there were significant changes
in the perceptions of peer norms in relation to HIV testing.
In fact, this change suggests that men are talking to each
other about their HIV testing behaviours. However, this
should not be confused with the issue of men talking to
each other about their HIV status. Again it is interesting to
speculate upon the role of the three social marketing cam-
paigns which ran in Scotland, all with a clear focus upon
promoting HIV testing. The fact that perceived benefits of
testing have changed at the community level is perhaps
indicative of the increased acceptability of HIV testing
(note that the measure used here relates to psychological
benefits rather than medical advances in HIV treatment,
which have remained relatively constant). Together these
findings are supportive of the idea of the normalization of
testing in that there have been key changes to the ways the
MSM community perceives HIV testing. The findings
suggest that HIV testing is an acceptable and normative
behaviour for this population.
Yet not all perceived barriers at the community level
have reduced. Fear of a positive result (the perceptions of
the meaning and consequences of HIV testing), clinic-
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related barriers (the opening times and waiting time asso-
ciated with testing) and attitudes to sex with HIV-positive
partners (the sexual exclusion of HIV-positive men by
HIV-negative and untested men) showed no significant
changes between data collection points. This suggests
certain deficits within the normalization of HIV testing;
some barriers to testing appear to endure despite an appar-
ent shift in both behaviour and community norm. Despite
the availability of testing through the opt-out policy, the
success of antiretroviral therapy, and the reduced risk of
transmission associated with undetectable viral load [27],
HIV infection remains to some extent a stigmatized and
dreaded condition [28].
The relevance of the perceptions at the community level
is further illuminated by the results of the regression analy-
sis. When controlling for time, age, educational attainment
and HIV risk-related behaviour, fear of a positive test result
remained important as a key barrier to testing. Equally,
attitudes to sex with positive men remained an impediment
to recent testing. Yet the significant fear ¥ year of survey
interaction term showed that the role of fear of a positive
test result had decreased in differentiating between those
who had never been tested and those who had; so,
although there is evidence that its role is diminishing, fear
of a positive test result remained particularly important in
explaining differences in testing behaviours. Therefore, our
findings suggest some disparity between biomedical and
psychosocial understandings of HIV. HIV normalization is
partial and not unidimensional. Much of what is proposed
within the ideas of HIV treatment as prevention relies on a
model of universal testing and the uptake of, and adher-
ence to, antiretroviral treatments [8]. This suggests that
the salience of barriers to HIV testing will become more
relevant to the full spectrum of HIV care. Maximizing
testing opportunities and reducing barriers to regular
testing will become a central component of HIV prevention
and, as such, devising innovative and evidence-informed
approaches to testing interventions is important.
The findings reported here reiterate the complexity of
HIV testing and the need for multifaceted public health
initiatives that address biomedical aspects of HIV testing
and the psychological, social and cultural contexts of
testing and its consequences. It seems likely that the key
challenge for developing effective HIV testing interven-
tions in a variety of contexts across Europe relates to
addressing these approaches in tandem. Challenging the
perceived sexual exclusion of HIV-positive men by
rethinking transmission risk in relation to testing and
treatment and the biomedical notion of infectivity at the
community level could be one useful example. Along these
lines, social marketing campaigns, for example, could
highlight the reduced infectivity of HIV-positive men who
are on treatment with undetectable viral loads, and simul-
taneously highlight the increased potential infectiousness
of those who have not tested recently (yet might be highly
infectious if they have recently seroconverted). In this way,
lack of recent and regular testing would become associated
with transmission risk (and concomitant stigma and sexual
exclusion) rather than positive HIV status per se. Equally,
in the context of opt-out testing, interactions with health
care providers at testing sites offer an opportunity to
explore in depth, and to challenge, men’s perceived bar-
riers to testing (such as fear of a positive result) through a
range of readily available intensive brief interventions
[29]. Thus, in order to promote the normalization of
testing as a core part of treatment as prevention (regular
and frequent testing, timely diagnosis, early treatment ini-
tiation, good adherence and reduced infectivity), it is vital
to address the meaning and significance of HIV within a
variety of MSM communities (namely HIV-related stigma
and challenging issues such as partner notification and
HIV status disclosure).
A recent systematic review [30] highlighted the paucity
of good-quality evidence relating to how best to promote
HIV testing among MSM. It did, however, note the promise
of particular approaches such as rapid testing and coun-
selling in community settings and intensive peer counsel-
ling. When combined with our findings, this suggest that
potential interventions aimed at addressing psychosocial
aspects of HIV testing – both the perceived consequences of
positive test results and negative attitudes to sex with
HIV-positive men – and harnessing normative influence to
increase the regularity and uptake of rapid tests within
community settings may well be viable candidate interven-
tions for further development and evaluation.
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